Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$148.36−1.16 (-0.78%)
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck Collaboration by Year
Collaboration — Eisai Co., Ltd. (Lenvima Oncology Alliance) ($M) ($M)
Merck Collaboration: $241M in FY2025, unchanged from a year earlier.
Latest, FY2025
241
Period ended Dec 31, 2025
Change on a year earlier
0.0%
241 in FY2024
History
8 years
Since FY2018
Sources
6
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-Q / 10-K Note 3/4 Collaborative Arrangements.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Collaboration — Eisai Co., Ltd. (Lenvima Oncology Alliance) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 241 | 0.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 241 | -36.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 381 | +79.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 212 | +8.7% | Form 10-K (filed 2025-02-25) ↗ |
| FY2021 | Dec 31, 2021 | 195 | -28.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 271 | +31.6% | Form 10-K (filed 2023-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 206 | -85.3% | Form 10-K (filed 2022-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 1,400 | – | Form 10-K (filed 2021-02-25) ↗ |
Breakdown
What makes up collaboration
- Eisai Co., Ltd. (Lenvima Oncology Alliance) — Current receivables from partner ($M)271 · FY2025
- Eisai Co., Ltd. (Lenvima Oncology Alliance) — Cost of sales profit-sharing & manufacturing ($M)241 · FY2025
- Eisai Co., Ltd. (Lenvima Oncology Alliance) — Net R&D cost-sharing expense ($M)11 · FY2025
- Eisai Co., Ltd. (Lenvima Oncology Alliance) — Commercialization / SG&A expense sharing ($M)134 · FY2025
Cite this data
StockData. (2026). Merck Collaboration ($M), annual FY2018–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/collab-eisai
See every metric in the Merck KPI table. Data updated Oct 26, 2026.